Anbio Biotechnology (NASDAQ:NNNN) Shares Gap Down – Time to Sell?

Anbio Biotechnology (NASDAQ:NNNN)’s share price gapped down prior to trading on Friday . The stock had previously closed at $21.51, but opened at $20.64. Anbio Biotechnology shares last traded at $21.5750, with a volume of 2,254 shares trading hands.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings raised Anbio Biotechnology from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Monday, February 9th. One research analyst has rated the stock with a Hold rating, According to data from MarketBeat, the company has an average rating of “Hold”.

Anbio Biotechnology Stock Up 2.0%

Anbio Biotechnology (NASDAQ:NNNN) last released its quarterly earnings data on Tuesday, December 30th. The company reported $0.04 earnings per share for the quarter. The company had revenue of $2.29 million for the quarter.

Anbio Biotechnology Company Profile

Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. Our unwavering commitment lies in transforming the diagnostics landscape on a global scale, fostering a paradigm shift towards personalized and decentralized diagnostic solutions. By doing so, we aim to significantly enhance patient prognosis and contribute to the betterment of healthcare worldwide. At Anbio Biotechnology, our extensive portfolio comprises an array of IVD products designed to cater to diverse diagnostic needs.